Prevention of cytomegalovirus infection by using leukocyte-depleted components.
Sayers
M
M
Puget Sound Blood Center and Program, Seattle, Wash.
D016913:Blood Component Transfusion / Q000009:adverse effects*; D001782:Blood Donors; D002498:Centrifugation; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D005374:Filtration; D006801:Humans; D007958:Leukocyte Count; D008403:Mass Screening / Q000379:methods; D012307:Risk Factors